Structure Therapeutics Inc. (GPCR) is in Healthcare, Biotechnology, based in United States, listed on NasdaqGM. Market cap 1.83B USD. 52-week range 25.09 to 94.90 USD. Data as of 2026-10-09.
Structure Therapeutics Inc., a clinical stage global biopharmaceutical company, develops and delivers novel oral small molecule therapeutics to treat various chronic diseases with unmet medical needs in the United States. Its lead product candidate is GSBR-1290, an oral and biased small molecule agonist of glucagon-like-peptide-1 receptor, which is in two phase 2 clinical trials for the treatment of obesity, overweight, and related conditions. The company also develops ACCG-2671 and ACCG-3535, ...